The Week

Aon (AON) fell 6.31% this week to close at $302.69, while the S&P 500 slipped 0.8%, leaving Aon about 5.51 percentage points behind the benchmark. The stock opened at $316.78 on Tuesday, 9 September, touched an intraday high of $321.57, then sold off to $303.59 on Wednesday, 10 September. It stabilised slightly on Thursday and slipped again on Friday to a weekly low of $302.44, a pattern of fading after an early push. Volume was heavy, with the weekly average of about 2.22m shares running roughly 75% above the 60-day median.

Key Events

Aon’s week centred on USI integration disclosures. On Friday, 11 September, the company released USI’s audited 2025 results, first-half 2026 financial statements and pro forma merger information. On the same day, data behind subsidiary-level transactions that shape the insurance industry also surfaced. The stock underperformed competitors on both Thursday and Friday, coinciding with this news flow. Earlier in the week, one research house voiced a pessimistic view on Aon’s FY2027 earnings. On the filings front, the week brought one material item: a 424B5 filing on 11 September.

Analyst Ratings

Aon is covered by 20 firms: 8 rate it buy, 3 overweight, 6 hold, 2 underweight and 1 sell. The consensus rating is buy, and the consensus target price of $382.67 sits about 26.4% above the latest close. Targets range from $266 to $433, a wide spread. Within the insurance-brokerage industry, Aon ranks fourth by analyst coverage, with noticeably more firms covering the stock than the peer average of 9 and median of 6.

The Week Ahead

Next week brings a busy US macro calendar. On Tuesday, 15 September, the New York Fed manufacturing index is due, with a prior reading of 20.6 and a forecast of 14.75. Wednesday, 16 September, brings retail sales excluding autos, import prices, retail control, retail sales, the NAHB housing market index, and weekly EIA crude and Cushing inventories. Whether this data can shift the relatively weak tone in financials is the key watchpoint.

In Short

Aon lagged the market this week, yet the consensus rating remains buy and the consensus target sits well above spot, even as the share price has slipped toward the bottom of its 60-day range. That gap is the central tension. The USI merger financials are now in the open, and the next question is whether incoming macro data can ease the relatively soft sentiment around insurance brokers and whether $302 holds.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.